| Name | 4-[(S)-[(2S,5R)-2,5-Dimethyl-4-(2-propenyl)-1-piperazinyl]phenylmethyl]-N,N-diethylbenzamide | 
|---|---|
| Synonyms | snc 162 | 
| Description | SNC162 is a delta-opioid receptor agonist with an IC50 of 0.94 nM. SNC162 has antidepressant-like effects and produces a selective enhancement of the antinociceptive effects of fentanyl in rhesus monkeys[1][2]. | 
|---|---|
| Related Catalog | |
| Target | 
                                
                                 IC50: 0.94 nM (delta-opioid receptor)[1]  | 
                        
| References | 
| Density | 1.027g/cm3 | 
|---|---|
| Boiling Point | 536.4ºC at 760mmHg | 
| Molecular Formula | C27H37N3O | 
| Molecular Weight | 419.60 | 
| Flash Point | 202.4ºC | 
| Exact Mass | 419.29400 | 
| PSA | 26.79000 | 
| LogP | 4.71440 | 
| Vapour Pressure | 1.4E-11mmHg at 25°C | 
| Index of Refraction | 1.549 | 
| Precursor 3 | |
|---|---|
| DownStream 0 | |